Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Fernmetastasen beim medullären Schilddrüsenkarzinom – welche Patienten überleben trotzdem?

Autor: Hubert G. Hotz, C König, S Siepmann, Elisabeth Schellhaas, Heinz-Johannes Buhr

Publikováno v: Zeitschrift für Gastroenterologie. 48

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5aeec4e12258f68bce84242a49c5c67b
https://doi.org/10.1055/s-0030-1263437

Zobrazit plný text záznamu

The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer

Autor: D, Pollmann, S, Siepmann, R, Geppert, K D, Wernecke, K, Possinger, D, Lüftner

Publikováno v: Anticancer research. 27(4A)

The efficacy control for the treatment of bone metastases in breast cancer is difficult and usually initiated later and with longer time between treatment cycles than the restaging of visceral or soft tissue metastases. The amino-terminal propeptide

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a747c78c4a34dd3119946ba04b05bd24
https://pubmed.ncbi.nlm.nih.gov/17649784

Zobrazit plný text záznamu

O167 First safety and response results of a randomized Phase III study with liposomal platin in the treatment of advanced squamous cell carcinoma of the head & neck (SCCHN)

Autor: D. Lüftner, Klaus-Dieter Wernecke, G. Pecher, S. Siepmann, Kurt Possinger, C. Jehn

Publikováno v: Oral Oncology Supplement. 2:118

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::40013932aa4ccda658f94e2f6ef13366
https://doi.org/10.1016/s1744-7895(07)70239-0

Zobrazit plný text záznamu

Tissue inhibitor of metalloproteinases 1 (TIMP-1) and tumor type M2 pyruvate kinase (TuM2-PK) were compared with established markers in advanced colorectal cancer

Autor: D. Pollmann, S. Siepmann, Klaus-Dieter Wernecke, D. Lueftner, Kurt Possinger, R. Geppert

Publikováno v: Journal of Clinical Oncology. 24:13537-13537

13537 Background: Recently, a high expression of TIMP-1 was demonstrated by immunohistochemistry in colorectal cancer (CRC). TIMP-1 can also be detected in plasma of those patients (pts). We investigated the longitudinal concentrations of TIMP-1 in 3

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::875fd967cab83bbe8638cb83f43b790b
https://doi.org/10.1200/jco.2006.24.18_suppl.13537

Zobrazit plný text záznamu

Randomized, phase III trial comparing liposomal platin with cisplatin in patients (pts) with advanced squamous cell carcinoma of the head & neck (SCCHN) regarding safety and efficacy profiles

Autor: Diana Lüftner, D. Pollmann, Klaus-Dieter Wernecke, G. Pecher, S. Siepmann, Kurt Possinger, J. Christian

Publikováno v: Journal of Clinical Oncology. 24:5564-5564

5564 Background: Based on a metanalysis of > 16,000 patients (Bourhis, ASCO 2004), cisplatin emerges as the essential agent for the treatment of advanced SCCHN. However, its clinical use is impeded by its severe adverse reactions, as renal toxicity.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::87355fa7ff1f61d9129f8b97ff4b10c6
https://doi.org/10.1200/jco.2006.24.18_suppl.5564

Zobrazit plný text záznamu